Advertisement

Topics

LifeCycle Pharma Company Profile

07:10 EDT 24th June 2018 | BioPortfolio

LifeCycle Pharma was founded in June 2002 as a spin-off from H. Lundbeck A/S. Its investors include H. Lundbeck A/S, Novo A/S, Nordic Biotech, Alta Partners (USA), and Adamant Biomedical Investments (Switzerland) as well as the LifeCycle Pharma executives. LifeCycle Pharma utilizes its proprietary Meltdose® technology to improve the bioavailability of known and established compounds so that patients can absorb them more effectively. LifeCycle Pharma's late-stage pipeline contains five products in clinical trials, of which the first - the cholesterol-lowering LCP-FenoChol® - is expected to reach the market in 2007.LifeCycle Pharma's strength is in selecting high-value drugs with absorbtion issues, improving their formulations, and taking them to the market in short time frames, thus substantially reducing risk as compared with other pharma and biotech companies.

Location

Kogle Allé 4
Hørsholm
DK-2970
Denmark

Contact

Phone: 45 70 33 33 00
Fax: 45 36 13 03 19
Email: info@lcpharma.com


News Articles [786 Associated News Articles listed on BioPortfolio]

$3.63 Bn Application Lifecycle Management (ALM) Market - Global Forecast to 2022

The Application Lifecycle Management (ALM) market is expected to grow from USD 2.58 Billionin 2017 to USD 3.63 Billionby 2022, at a Compound Read more...

Global and Chinese Service Lifecycle Management Application Industry, 2017 Market Research Report [Report Updated: 23122017] Prices from USD $3000

The 'Global and Chinese Service Lifecycle Management Application Industry, 20122022 Market Research Report' is a professional and indepth study on the current state of the global Service Lifecycle Man...

Global and Chinese Contract Lifecycle Management Software Industry, 2017 Market Research Report [Report Updated: 19122017] Prices from USD $3000

The 'Global and Chinese Contract Lifecycle Management Software Industry, 20122022 Market Research Report' is a professional and indepth study on the current state of the global Contract Lifecycle Mana...

Novel uses for oral solid doses driving lifecycle management strategies

With few potential blockbuster drugs in the pharma pipeline right now, drug companies are increasingly looking at other options to meet the needs of patients and increase revenue in the oral...

Porton Pharma Solutions and BioDuro announce strategic alliance

Porton Pharma Solutions, a leading provider of custom, cross lifecycle active pharmaceutical ingredient (API) development and cGMP manufacturing services to the global drug industry, and BioDuro LLC,...

PTV News: Oct 6, 2009

Top stories on October 6th, 2009: Sanofi launch generic of their own drug Plavix Trimeris sold to Arigene for $81M Sandoz CEO: 10 new drugs a year in Japan CBR Pharma Insights on ‘lifecycle...

Global Brand Launches: Examining Allocation by Lifecycle Stage

The post Global Brand Launches: Examining Allocation by Lifecycle Stage appeared first on Competitive Intelligence Performance Metrics | Cutting Edge Information.

Lifecycle Biotechnologies, Parent Company to Boval BioSolutions, Chata Biosystems and VI Plastics Announces Rebranding

Rebranding efforts will provide customers with more and enhanced product offerings under a unified marketing message and align the way Lifecycle operates internally around its three major market divis...

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [54 Associated PubMed Articles listed on BioPortfolio]

Moving pharma contracting into the era of accountability.

Developing SAICM into a framework for the international governance of chemicals throughout their lifecycle: Looking beyond 2020.

The 164 K, 165 K and 167 K residues in 160YPVVKKPKLTEE171 are required for the nuclear import of goose parvovirus VP1.

goose parvovirus (GPV) belongs to the Dependoparvovirus genus in Parvovirinae subfamily within Parvoviridae family, is the etiological agent of Derzsy's disease. Nuclear localization signal (NLS) is i...

A guide to manufacturing CAR T cell therapies.

In recent years, chimeric antigen receptor (CAR) modified T cells have been used as a treatment for haematological malignancies in several phase I and II trials and with Kymriah of Novartis and Yescar...

International Congress on Soldiers' Physical Performance 2017: Research priorities across the service members operational lifecycle.

Clinical Trials [86 Associated Clinical Trials listed on BioPortfolio]

Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily

This is 2-armed parallel group, prospective, randomized, open-label, multicenter Phase 3 controlled trial to establish the efficacy and safety of conversion from maintenance immunosuppress...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

Companies [860 Associated Companies listed on BioPortfolio]

LifeCycle Pharma

LifeCycle Pharma was founded in June 2002 as a spin-off from H. Lundbeck A/S. Its investors include H. Lundbeck A/S, Novo A/S, Nordic Biotech, Alta Partners (USA), and Adamant Biomedical Investments (...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies, ...

FranceMed Pharma

FranceMed Pharma is a Research, Development, FMCG Manufacturer and Global Marketing Company established since 1981. FranceMed Pharma owns Magicool® brand and the world-wide patents and technology. Fr...

More Information about "LifeCycle Pharma" on BioPortfolio

We have published hundreds of LifeCycle Pharma news stories on BioPortfolio along with dozens of LifeCycle Pharma Clinical Trials and PubMed Articles about LifeCycle Pharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of LifeCycle Pharma Companies in our database. You can also find out about relevant LifeCycle Pharma Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record